drugset / Trial / NCT01345578

Hepatocyte Transplantation for Liver Based Metabolic Disorders

NCT01345578 ↗

Phase 1 Terminated 5 enrolled Ira Fox
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to determine whether partial irradiation of the liver and liver cell transplantation can provide help for patients with life-threatening liver-based metabolic diseases who are unlikely to survive without extensive medical therapy or transplant. The goal of this research study is to determine if liver cell transplants can be effective as an alternative to organ transplantation. At the present time, liver cell transplants are experimental and have been done in a limited number of human subjects.

Timeline

Start
2011-03
Primary completion
2022-03-31
Completion
2022-03-31

Outcome

Outcome not reported

Stopped (Business): “seeking additional funding”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject human hepatocyte transplantation Cell therapy — Other

Indications